NorthWest Biotherapeutics Inc (NWBO)

[gropgrip]

You wrote:

So I do find it "odd" that they indicate they "have not yet decided whether to go beyond the 233 events", if they have been informed that these 233 events have already occurred. If they are now at 235 or 237 events, for example, then when do they intend to make a decision whether they will go beyond the 233?

1) If they decided, they wouldn`t tell the individual investor on the phone.

2) If we assume he is telling the truth, maybe they are waiting on the impact of the publication on the stock, insiders and FDA. Maybe even insiders get to buy back. Imagine NWBO giving an enthusiastic publication that discloses insider knowledge. Neil Woodford would be free to resume buying. If he did, that would catapult the price near his avg quickly. And god knows Neil needs a win after Mystic trial (although Astrazeneca is recouperating after good news @ESMO) and Provident financials disaster. It would make his initial investment in NWBO look less bad. For NWBO this would mean, that they could go on with long tail and so on, replacing uncertanties with certanties as flipper put it.
Now: if neither FDA is impressed or even worse, nor PPS starts climbing: Then the decision might be to data lock, unblind and analyze and so on